Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?

Maximus, Inc. MMS presents investors with a sharp valuation-versus-visibility trade-off. The stock trades at a deep earnings discount and still carries favorable fundamental Style Scores, while recent profitability has held up better than revenues.

The offset is near-term uncertainty. Federal procurement delays, contract sensitivity and downward earnings estimate revisions make the low multiple less straightforward than it first looks.

Maximus Trades at a Deep Earnings Discount

MMS trades at about 6.2X forward 12-month earnings, well below the Zacks sub-industry's 11.2X and its own five-year median of roughly 13.9X. The current multiple is also near the bottom of its five-year range of 6.2X to 20.5X.

                                                                 Image Source: Zacks Investment Research

That discount can appeal to value-focused investors, but it reflects weaker growth visibility rather than a simple market mispricing. Shares have fallen 35.6% in the past year as contract and procurement concerns have weighed on expectations.

                                                                 Image Source: Zacks Investment Research

MMS Earnings Growth Faces a Near-Term Reset

Fiscal 2026 revenues are estimated at about $5.2 billion, down from $5.43 billion in fiscal 2025, before rising to roughly $5.43 billion in fiscal 2027. The top line therefore points to a reset before growth resumes.

Earnings trends are firmer. The fiscal 2026 earnings estimate of $8.46 per share implies 14.9% growth, while third-quarter adjusted earnings rose 2.8% year over year to $2.22. Adjusted EBITDA margin also improved to 15.0% from 14.7%, helped by efficiency initiatives and AI-enabled tools.

Maximus Pipeline Size Masks Conversion Risk

Maximus ended June with a $50.4 billion sales pipeline, but year-to-date signed awards were only $1.25 billion and the trailing 12-month book-to-bill ratio was 0.5 times. Awarded but unsigned contracts totaled another $1.35 billion.

Federal agencies are taking longer to complete procurements, revising scopes and relying more on bridge contracts and short-term extensions. Booz Allen Hamilton Holding Corporation BAH, a major provider of technology solutions to government customers, offers investors another way to assess federal spending trends. ICF International, Inc. ICFI, which serves federal, state, local and commercial clients, has also highlighted the importance of client diversification as federal work remains uneven.

MMS Liquidity Supports Patience Through Volatility

Maximus had $1.65 billion of debt at June 30, with net leverage of 2.0 times and about $730 million available under its revolving credit facility. That gives the company room to absorb temporary working-capital pressure.

The pressure was visible in the third quarter, when operating cash flow was an outflow of $125 million and days sales outstanding reached 98. Collections improved after quarter-end, including about $245 million received from a major federal customer, easing some of the near-term liquidity concern.

Maximus Signals Favor Value but Warn on Timing

The valuation and operating profile still have attractions, but timing remains the central issue. Maximus currently carries a Zacks Rank #5 (Strong Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

This reflects unfavorable earnings estimate revision trends and argues against treating the low multiple alone as a buy signal.

At the same time, MMS has a Value Score of A, Growth Score of B, Momentum Score of B and VGM Score of A. Those grades point to favorable value and fundamental characteristics, but Zacks Style Scores are designed to complement the Zacks Rank, not override it. Under that framework, the setup favors patience until estimate trends improve, despite the stock's unusually low valuation.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research